North American Lithium’s Québec operation will supply spodumene concentrate to Mangrove Lithium’s proposed Eastern Canada conversion facility.
By Sonny Rollins
Elevra Lithium has signed a binding agreement to supply spodumene concentrate from its North American Lithium operation in Québec to Mangrove Lithium’s proposed 20,000-tonne-per-year lithium carbonate equivalent conversion facility in Eastern Canada, strengthening efforts to build a domestic mine-to-chemicals supply chain.
The agreement converts a non-binding memorandum of understanding signed in February into a long-term commercial arrangement. It commits Elevra to supply 122,000 dry metric tonnes of spodumene concentrate in the first year and 144,000 dmt annually from the second year onward, subject to the project conditions set out in the agreement.
The initial term is seven years, with a further seven-year renewal option. Volumes are structured on a take-or-pay basis, meaning Mangrove would be required to pay for the contracted quantity even if it does not take the full volume, subject to the agreement’s terms and conditions.
The deal arrives as Canada seeks to retain more value from its critical minerals production by linking domestic mines with refining and chemical conversion capacity. For Elevra, the arrangement provides a local customer for a portion of NAL’s output. For Mangrove, it secures a proposed feedstock source for a facility designed to produce battery-grade lithium chemicals.
Deal at a glance
| Item | Agreement terms |
|---|---|
| Supplier | Elevra Lithium (ASX: ELV; Nasdaq: ELVR) |
| Mine | North American Lithium, Québec |
| Buyer | Mangrove Lithium |
| Product | Spodumene concentrate at a 6% Li₂O equivalent specification |
| Proposed conversion facility | 20,000 tonnes per year of lithium carbonate equivalent |
| Initial term | Seven years |
| Renewal option | Seven additional years |
| Year-one volume | 122,000 dmt |
| Year-two volume onward | 144,000 dmt annually |
| Commercial structure | Take-or-pay |
| Volume flexibility | Mangrove may increase contracted volumes by up to 20% |
| Pre-commercial purchases | Up to 72,000 dmt |
| Pricing | Linked to market-based spodumene concentrate prices |
| Price protection | Floor above Elevra’s expected production cost; no price ceiling |
| Key project condition | Mangrove must reach final investment decision by Dec. 31, 2028 |
| Commercial start requirement | Within three years of FID |
Local supply replaces part of the seaborne route
The agreement gives Elevra a long-term local customer rather than relying exclusively on seaborne shipments to overseas converters.
Elevra Chief Executive Lucas Dow said the arrangement would support a “long-term local customer” for NAL and help avoid seaborne freight. The Québec mine is located in the Abitibi region, an established mining district with access to transport infrastructure and hydroelectric power.
Elevra describes NAL as its flagship operation and says the mine has a JORC-compliant mineral resource of 95 million tonnes grading 1.15% lithium oxide, alongside a mineral reserve of 49 million tonnes grading 1.11% lithium oxide. The operation produces spodumene concentrate for battery markets.
For a producer, the difference between selling concentrate into a global merchant market and supplying a nearby conversion facility can extend beyond freight costs. A domestic customer may improve logistics visibility, simplify coordination between mine and plant and create a clearer chain of custody for buyers seeking North American-origin materials.
The agreement does not eliminate exposure to lithium prices. Its pricing formula remains linked to the spodumene concentrate market. However, the inclusion of a price floor above Elevra’s expected production cost is intended to provide downside protection while the absence of a price ceiling leaves the producer exposed to higher market prices.
That structure is important for any lithium price forecast 2026. Concentrate contracts can offer revenue visibility, but market-linked formulas still transmit changes in lithium demand, inventories, conversion margins and battery-sector purchasing into the value of the underlying material.
Spodumene concentrate is the feedstock that will move from NAL into Mangrove’s proposed conversion chain.
Mangrove secures feedstock for a Canadian converter
Mangrove plans to use the concentrate in a proposed 20,000-tpa facility capable of producing battery-grade lithium hydroxide or lithium carbonate. The company’s Clear-Li technology is designed to convert lithium chloride or lithium sulfate from multiple feedstocks into high-purity lithium chemicals.
Mangrove Chief Executive Saad Dara said the agreement would support an integrated mine-to-chemicals supply chain within Canada. The company has demonstrated its conversion technology at a pilot plant in Delta, British Columbia, and has been working toward commercial-scale deployment.
The company says its process is designed to reduce chemical consumption and avoid some capital-intensive steps used in conventional refining. Its modular approach is intended to allow facilities to be located near mines, recyclers or battery manufacturers.
The NAL agreement gives that strategy a defined upstream source. Mangrove may increase purchases by up to 20% and may buy as much as 72,000 dmt before commercial operations begin. Those provisions provide flexibility during commissioning and could allow the parties to manage changes in plant ramp-up, concentrate availability or customer requirements.
The agreement is not an unconditional commitment to build the facility. Mangrove must reach a final investment decision by Dec. 31, 2028, and begin commercial operations within three years of that decision. The project therefore remains subject to financing, engineering, permitting, construction and commissioning risks.
Those conditions are central for investors and policymakers tracking the development of Canada’s processing capacity. A signed offtake agreement can support financing and project planning, but it does not by itself establish that a conversion plant will be built or that commercial production will begin on schedule.
Government-backed critical minerals strategy
Both companies have links to the Canada Growth Fund, a C$15 billion investment vehicle established to support economic growth and the country’s transition to a lower-carbon economy.
Mangrove secured up to US$85 million in structured financing led by the Canada Growth Fund in January. Elevra has also received a convertible note investment backed by the fund. The capital support reflects the government’s interest in developing domestic capacity for minerals considered strategically important to electrification and advanced manufacturing.
The agreement is consequently relevant to the wider critical minerals supply chain 2026 discussion. Canada has substantial mineral resources and an established mining sector, but its ability to capture downstream value depends on processing, chemical conversion, transport, financing and customer qualification.
Lithium projects face an additional challenge: a mine can produce concentrate without creating a complete battery-materials supply chain. The material must still be converted into a chemical form that cathode and battery manufacturers can use. Domestic conversion capacity can reduce dependence on overseas processing, although it also introduces new requirements for plant technology, operating expertise and market access.
Electrochemical conversion requires specialized equipment, process control and reliable feedstock supply.
What the agreement changes
The binding agreement changes the relationship between Elevra and Mangrove in three ways.
First, it replaces the uncertainty of the February MOU with defined volumes, pricing principles and project milestones. The initial seven-year term also gives both parties a longer planning horizon than a spot-market transaction.
Second, the take-or-pay structure gives Elevra a measure of volume certainty. The 144,000-dmt annual commitment from year two would represent a substantial contracted stream from NAL, although the final share of mine production will depend on the operation’s output and sales profile.
Third, the arrangement links mine development with downstream construction. Mangrove’s proposed plant has a committed feedstock source, while Elevra has a potential local outlet for concentrate. That interdependence may help the companies coordinate financing and engineering, but it also means delays at either end could affect the other party.
The broader test will be execution. Mangrove must reach FID by the contractual deadline, complete construction and start commercial operations within the agreed period. Elevra must maintain production, meet concentrate specifications and deliver the contracted volumes. Both companies will also remain exposed to lithium-market volatility and changes in battery chemistry, policy and customer demand.
For Canada’s mining sector, the agreement is a concrete example of the policy objective behind domestic critical-minerals development: connect resource extraction with processing inside the country. Whether that model becomes commercially durable will depend on the cost of local conversion, the competitiveness of Canadian supply and the ability of projects to move from financing commitments to operating assets.
Shareable social snippet
LinkedIn/X: Elevra Lithium has signed a binding seven-year agreement to supply Québec spodumene concentrate to Mangrove Lithium’s proposed 20,000-tpa Eastern Canada converter. The deal includes take-or-pay volumes, a price floor above expected production cost and a pathway toward a domestic Canadian mine-to-chemicals lithium supply chain. Read more